Search
Kymera Therapeutics Inc
KYMRAdd to Watchlist
116.995USD
+7.675+7.02%
Market hours （ET）Quotes delayed by 15 min
9.61BMarket Cap
LossP/E TTM
Revenue Breakdown
FY2025
FY2024
Relevant data have not been disclosed by the company yet.
By RegionUSD
Name
Revenue
Proportion
United States
39.21M
0.00%
By Business
By Region
Relevant data have not been disclosed by the company yet.
